Damora Therapeutics, Inc.
DMRA · Pharmaceutical Preparations · 61.6M shares · -64%/yr ↓ buyback · EDGAR filings ↗
Reference price $21.38 · est. market cap ~$1.3B — last insider sale, 2026-01-02 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Clinical/early-stage biotech — clinical-stage biotech, very cash-rich.
Strengths
- Liquidity — current ratio 13.0 (86th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Auditor changeRecent 8-K item 4.01 8-K ↗
- Buying back stockNet buyback — share count -64%/yr over 3y
- Strong balance sheetStrong balance sheet — $258M cash & investments
- New fund positionNotable fund(s) opened this quarter: STATE STREET CORP, GOLDMAN SACHS GROUP INC
- AccumulatingInstitutional holders rose 2→5 QoQ (2025-12-31→2026-03-31)
- Insider sellingInsider selling — 3 open-market sale(s) by 3 insider(s) (cluster of 3 insiders, last 6mo) Form 4 ↗
- Notable holderHeld by 3 notable fund(s): FMR LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC (as of 2026-03-31)
Key metrics
Return on equity
-87.3%
Return on assets
-80.5%
Current ratio
13.0×
Tangible book value
$240M
Cash & investments
$258M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-30 | Jarrett Jennifer | Grant | 500K | — |
| 2026-02-09 | Bruno Julianne | Option exercise | 129K | — |
| 2026-02-09 | Fairmount Funds Management LLC | Option exercise | 5.8M | — |
| 2026-02-09 | Fairmount Funds Management LLC | Option exercise | 2.9M | — |
| 2026-01-05 | Sattarzadeh Sherwin | Grant | 190K | — |
| 2026-01-05 | Hewes L. Becker | Grant | 265K | — |
| 2026-01-02 | Schambye Hans T. | Option exercise | 1.4K | — |
| 2026-01-02 | Schambye Hans T. | Sell | 700 | $21.38 |
| 2026-01-02 | Winslow Garrett | Option exercise | 680 | — |
| 2026-01-02 | Winslow Garrett | Sell | 255 | $21.38 |
| 2026-01-02 | Firmani Lori | Option exercise | 374 | — |
| 2026-01-02 | Firmani Lori | Sell | 135 | $21.41 |
| 2025-07-03 | Schambye Hans T. | Option exercise | 1.4K | — |
| 2025-07-03 | Schambye Hans T. | Sell | 735 | $3.38 |
| 2025-07-03 | Winslow Garrett | Option exercise | 680 | — |
| 2025-07-03 | Winslow Garrett | Sell | 260 | $3.39 |
| 2025-07-03 | Firmani Lori | Option exercise | 374 | — |
| 2025-07-03 | Firmani Lori | Sell | 147 | $3.39 |
| 2025-01-03 | Winslow Garrett | Option exercise | 1.3K | — |
| 2025-01-03 | Winslow Garrett | Sell | 471 | $5.60 |
| 2025-01-03 | Firmani Lori | Option exercise | 726 | — |
| 2025-01-03 | Firmani Lori | Sell | 261 | $5.63 |
| 2025-01-03 | Schambye Hans T. | Option exercise | 2.6K | — |
| 2025-01-03 | Schambye Hans T. | Sell | 1.3K | $5.60 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-17 | Shareholder vote | filing ↗ |
| 2026-05-04 | Exec/director changeExhibits | filing ↗ |
| 2026-04-20 | Auditor changeExhibits | filing ↗ |
| 2026-03-23 | Exec/director changeReg FDExhibits | filing ↗ |
| 2026-03-10 | Results5.03Reg FDExhibits | filing ↗ |
| 2026-02-11 | Material agreementExhibits | filing ↗ |
| 2026-02-10 | Exec/director change5.03OtherExhibits | filing ↗ |
| 2026-01-12 | Reg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-17 | 2026-04-28 | 0001193125-26-274093 ↗ |
| 10-Q | 2026-05-12 | 2026-03-31 | 0001193125-26-219327 ↗ |
| 8-K | 2026-05-04 | 2026-04-28 | 0001193125-26-203913 ↗ |
| 8-K | 2026-04-20 | 2026-04-17 | 0001193125-26-163909 ↗ |
| 8-K | 2026-03-23 | 2026-03-20 | 0001193125-26-118699 ↗ |
| 10-K | 2026-03-19 | 2025-12-31 | 0001193125-26-115922 ↗ |
| 8-K | 2026-03-10 | 2026-03-06 | 0001193125-26-099404 ↗ |
| 8-K | 2026-02-11 | 2026-02-10 | 0001193125-26-046817 ↗ |
| 8-K | 2026-02-10 | 2026-02-06 | 0001193125-26-043741 ↗ |
| 8-K | 2026-01-12 | 2026-01-12 | 0001193125-26-009812 ↗ |
| 8-K | 2026-01-06 | 2025-12-31 | 0001193125-26-003490 ↗ |
| 8-K/A | 2025-12-09 | 2025-11-10 | 0001193125-25-312912 ↗ |